drugset / Trial / NCT02427412

Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty

NCT02427412

Phase 4 Completed 60 enrolled Hvidovre University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized, prospective, placebo-controlled study which aims to evaluate the effect of combined intraarticular and intravenous Tranexamic acid on total blood loss following unilateral knee replacement versus only intravenous tranexamic acid.

Timeline

Start
2014-01
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Other
Comparator Tranexamic Acid Small molecule 3 g Other